amanda

266 POSTS 0 COMMENTS

Edwards PCR London Valves TNT symposium summary: reviewing the impact from...

In this video, hear how key recommendations from the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease may affect TAVI practices and...

Cardiovascular News Issue 47 – November 2017 US edition

Highlights: SPYRAL HTN-OFF MED provides "proof of principle" that renal denervation lowers blood pressure Rate of target lesion failure significantly lower with Orsiro than...

Cardiovascular News Issue 47 – November 2017

Highlights: SPYRAL HTN-OFF MED provides "proof of principle" that renal denervation lowers blood pressure Rate of target lesion failure significantly lower with Orsiro than...

Delayed diagnosis affects women’s treatment for heart disease

Woman patient
Factors such as delayed diagnosis may contribute to the differences in women and men’s treatment for heart disease, rather than gender bias alone. Women with...

BioCardia phase III CardiAMP trial passes interim safety analysis

BioCardia CardiAMP
The independent Data Safety Monitoring Board (DSMB) has found no significant safety concerns with BioCardia’s CardiAMP trial results. It recommends that the study continue...

Medtronic HeartWare HVAD approved for destination therapy

The US Food and Drug Administration (FDA) has approved Medtronic’s HeartWare HVAD system as a destination therapy for patients with advanced heart failure who...

US FDA accepts PMA application for TherOx’ SSO2

TherOx' SSO2
The US Food and Drug Administration (FDA) has accepted TherOx’ Premarket Approval (PMA) application for its Supersaturated Oxygen (SSO2) Therapy system. The second-generation system...

US FDA approves coronary indication for ReFlow’s Wingman

ReFlow Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Wingman14C crossing catheter for use in conjunction...

FDA issues class I recall for Spectranetics’ Bridge occlusion balloon catheter

Spectranetics' Bridge
Spectranetics has recalled the Bridge occlusion catheter “due to the possibility of a blocked guidewire lumen in some device units”. Using affected catheters could...

New performance and quality measures for treating heart attack patients

The American College of Cardiology (ACC) and the American Heart Association (AHA) have released updated clinical performance and quality measures to benchmark and improve...

Creavo’s Vitalscan “rule out” technology on show at EUSEM

Creavo's Vitalscan
A new scanning device designed to aid cardiac ‘rule out’ is to be exhibited at the EUSEM European Society of Emergency Medicine conference (EUSEM;...

Re-interventions common in long-term Fontan procedure survivors

Toddler
Among patients who undergo the Fontan procedure, two-thirds of survivors require a surgical or catheter-based procedure within 20 years. Paediatric cardiology researchers note that...

Average age and income of US cardiologists on the rise

According to a new survey, the average age and income of cardiologists in the US are increasing. The fifth annual Cardiovascular Provider Compensation &...

US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty...

BioStable Science & Engineering has received US Food and Drug Administration (FDA) market clearance for the HAART 200 aortic annuloplasty device. This is the...

“Singheart” offers step towards heart regeneration

New research has discovered a potential means to trigger damaged heart cells to self-heal. For the first time, researchers have identified a long non-coding...

Heart failure patient and clinician risk perceptions differ drastically

Woman patient
Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while...

Medtronic to undertake global randomised clinical trial of one-month DAPT in...

Medtronic has announced a global randomised clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT) in patients implanted with the Resolute Onyx drug-eluting...

HeartFlow FFRct Analysis receives four Blue Cross Shield endorsements

Four Blue Cross Shield companies have issued positive medical policies for the HeartFlows FFRct Analysis. Horizon Blue Cross Blue Shield of New Jersey, Blue...

Marijuana use associated with three-fold risk of death from hypertension

Marijuana use is associated with a three-fold risk of death from hypertension, according to research published in the European Journal of Preventive Cardiology. “Steps are...

LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on...

LivaNova’s Perceval sutureless aortic heart valve has received approval from the US Centers for Medicare and Medicaid Services (CMS) for a New Technology Add-on...

Social inequality may impact adult cardiovascular risk before birth

Children from socially and economically disadvantaged families and neighborhoods appear more likely to have thicker carotid artery walls. In adults, this may indicate higher...

French doctors revise emergency plans to better deal with terrorism

In a Viewpoint published in The Lancet, Pierre Carli (University Paris-Descartes, Paris, France; SAMU de Paris, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP),...

New PET-CT scan improves detection of sarcoidosis secondary to cardiac

Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests, researchers from the University of Illinois at Chicago...

Millipede 50mm annuloplasty ring used in first cases

Millipede has announced the successful implantation of its newest 50mm Iris annuloplasty ring, with a transfemoral, transseptal delivery catheter, in a functional mitral regurgitation...

European Medicines Agency issues positive opinion for rivaroxaban

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion on a label update...

4C Medical receives over US$8 million financing for transcatheter mitral regurgitation...

4C Medical has received approximately US$9 million in unsecured convertible promissory notes. The company is focused on the development of minimally invasive therapies for...

Some plant-based diets associated with higher risk of heart disease

Plant-based diets are recommended to reduce the risk of heart disease; however, some plant-based diets are associated with a higher risk of heart disease,...

Cardiovascular drugs behind almost a quarter of medication error-related serious medical...

Every 21 seconds someone in the USA calls Poison Control because of a medication error. A new study from the Center for Injury Research...

Meta-Analysis compares the safety and efficacy of S-DAPT and L-DAPT at...

Researchers have evaluated the long-term efficacy and safety of long duration dual anti-platelet therapy (L-DAPT) compared to short duration DAPT (S-DAPT) after drug-eluting stent...

GE Healthcare and HeartFlow announce global collaboration

GE Healthcare and HeartFlow have entered into a global collaboration agreement with the goal of increasing the clinical availability and adoption of HeartFlow FFRct. Announced...

Sildenafil-coated stent may help prevent blood clots and restenosis

A stent coated with sildenafil (Viagra, Pfizer, and others) may someday help prevent arteries from becoming narrow or blocked again, according to preliminary research...

Radical changes required to ensure US women receive optimal healthcare

Radical changes to our health care system that take into account the unique needs of women, including minority populations, are needed to ensure women...

Medtronic releases Resolute Onyx drug-eluting stent in Japan

Medtronic will release the Resolute Onyx coronary stent system in Japan. According to a press release, the device offers superior deliverability to that of...

AMA issues unique Category III Current Procedural Terminology codes for HeartFlow...

The American Medical Association (AMA) has issued a set of new Category III Current Procedural Terminology (CPT) codes for HeartFlow FFRct, a first-of-its-kind noninvasive...

First German order for Acarix’ CADScore system

A private cardiology clinic in Berlin, Germany, headed by Niels Jacobsohn has placed the first order in the important German market for Acarix’ CADScor...

Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates

Researchers at Georgia Institute of Technology and the Piedmont Heart Institute (both Atlanta, USA) are using standard medical imaging and new 3-D printing technologies...

Shingles associated with stroke and heart attack

Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack, according to a research letter published today...

Europace 2017: Breast implants may lead to false heart attack diagnosis

Breast implants may disrupt an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research presented at EHRA EUROPACE -...

Obamacare health insurance expansion linked to fewer cardiac arrests

A sudden catastrophic loss of heart function, or cardiac arrest, occurred significantly less among adults who acquired health insurance via the Affordable Care Act...

Childhood asthma may lead to thickening of left ventricle in adulthood

Young adults with a history of asthma are at a greater risk of thickening of the left ventricle according to research published today in...

Teleflex’s Vascular Solutions issues recall of Venture catheters

A worldwide recall of Venture catheters has been voluntarily initiated by its Teleflex’s Vascular Solutions subsidiary. Vascular Solutions, is the manufacturer of Venture catheters,...

Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart...

Novartis has announced topline results from the global Phase III CANTOS study investigating the efficacy, safety and tolerability of canakinumab (ACZ885) in combination with...

Nearly half of US women unaware that heart disease is their...

Women and their physicians are largely uneducated when it comes to females and heart disease, putting women’s health and lives at greater risk, a...

Negative late lumen loss at 24 months for TriReme Chocolate Heart

TriReme Medical, a subsidiary of QT Vascular, has announced that its angiographic data from a 24-month follow-up of patients with de novo lesions treated...

Italian boy becomes youngest patient bridged to transplant with the SynCardia...

A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be bridged to a heart transplant...

UK public health groups launch “Everyday Interactions” toolkit to measure professionals’...

Public Health England (PHE) and the Royal Society for Public Health (RSPH) have published “Everyday Interactions”, a report which aims to support healthcare professionals...

US FDA grants clearance to FlowGlide technology from ClearFlow

The United States Food & Drug Administration (FDA) has granted 510(k) clearance for ClearFlow’s proprietary FlowGlide active clearance technology system. The device is the next...

German court awards Edwards Lifesciences co-entitlement of Neovasc’s Tiara patent application

The District Court in Munich, Germany has partially found in favour of Edwards Lifesciences Corporation (formerly CardiAQ Valve Technologies) in its case against Neovasc.  In...

Sapien 3 receives expanded FDA indication for valve-in-valve procedures

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for aortic and mitral valve-in-valve procedures using the Edwards Sapien 3 transcatheter heart...

First procedures using Edward Lifesciences’ Inspiris Resilia aortic valve take place

The first ever Inspiris Resilia aortic valve (Edwards Lifesciences) implantation procedures have successfully taken place in two UK hospitals—King’s College and Royal Brompton and...

Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched

Philips has announced the relaunch of the Pioneer Plus catheter, described as the only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment...

EuroPCR 2017: Micell Technologies’ MiStent non-inferior to Abbot Xience in all-comers...

Micell Technologies has announced positive twelve-month data from its DESSOLVE III clinical trial comparing the company’s MiStent with Abbott’s Xience. The study met its...

Michael Buck named HeartFlow executive vice president and chief commercial officer

HeartFlow has announced the appointment of Michael Buck as executive vice president and chief commercial officer. Effective immediately, Buck will be responsible for expanding...

Ultra-sensitive cardiac troponin test using Single Molecule Counting technology receives CE...

Singulex has been granted CE mark for its ultra-sensitive troponin assay (cTnl), the first offered by the company’s Sgx Clarity system, a fully-automated, in...

US FDA clears Stroke2prevent’s A-View balloon catheter

The US Food and Drug Administration (FDA) has cleared Stroke2prevent’s A-view device for commercialisation on the US market. The A-view is a balloon catheter...

Statins associated with improved heart structure and function

Statins are associated with improved heart structure and function, according to research presented at the annual Cardiovascular Magnetic Resonance conference of the European Association...

Halting methamphetamine abuse can reverse related heart damage

Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical...

Diesel pollution linked to structural and functional heart damage

Diesel pollution is linked with heart damage, according to research presented at the annual Cardiovascular Magnetic Resonance conference of the European Association of Cardiovascular...

First Revivent TC ventricular enhancement procedure for ischaemic cardiomyopathy performed

BioVentrix has announced the first clinical use of its closed-chest Revivent TC transcatheter ventricular enhancement system at the Deutsches Herzzentrum Berlin in Berlin, Germany....

Transendocardial delivery results in greater myocardial stem cell therapy retention

According to a study published in the International Heart Journal, delivery of stem cell therapy to the heart using BioCardia’s Helix transendocardial delivery system...

EuroPCR 2017: Excellent clinical outcomes for Medtronic’s CoreValve and Evolut systems...

New positive data on the self-expanding Medtronic CoreValve platform from the CoreValve ADVANCE and Evolut R FORWARD clinical studies—two large, rigorous global registries—have been...

Sponsored: Patients have to trust that if I were in their...

  Drug-eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis and revascularisation procedures. Still there remains...

Abiomed introduces third generation Impella CP heart pumps at SCAI 2017

Abiomed has announced the debut of the third generation Impella CP heart pump at the Annual meeting of the Society for Cardiovascular and Angiography...

Boston Scientific to present REPRISE III and EWOLUTION data at EuroPCR

Boston Scientific has announced the schedule of key data presentations, including four late-breaking clinical trials, which will be featured at the annual EuroPCR Scientific...

Large nuclear cardiology laboratory slashes radiation dose by 60% in eight...

A large nuclear cardiology laboratory has slashed its average radiation dose by 60% in eight years, according to new research presented today at the...

FDA approves Medtronic’s Resolute Onyx drug-eluting stent

The FDA has approved Medtronic’s Resolute Onyx drug-eluting stent, which the company has now launched in the USA. “As stent technologies continue to evolve, recent...

Non-O blood groups associated with higher risk of heart attack

Having a non-O blood group is associated with a higher risk of heart attack, according to research presented at Heart Failure 2017 and the...

US FDA designates Medtronic HVAD system controller field action as class...

The US Food and Drug Administration (FDA) has classified Medtronic’s recently initiated voluntary field action related to its HVAD system controllers and direct current...

First patient enrolled in new study of abbreviated DAPT post-stent in...

Gillian Jessurun (Treant Zorggroep, Scheper Hospital Emmen, The Netherlands) has enrolled the first patient in the investigator-initiated MASTER DAPT (Management of patients post bioresorbable...

Cordis granted CE mark for Railway sheathless access system

Cordis has received the CE mark for its new Railway sheathless access system, which is now available in select countries across Europe. Railway is...

LATERAL study offers positive overall results for Medtronic HVAD

Preliminary results from the Medtronic -sponsored HVAD LATERAL study have demonstrated overall positive results. The data were presented as a late breaking clinical trial...

Microport TARGET AC three-month sub-study results to be presented at EuroPCR

Results of the TARGET All Comer (AC) clinical trial will be released at annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR;...

Occlutech obtains CE mark for its Perimembranous ventricular septal defect occluder

Occlutech has obtained CE mark approval for its Perimembranous ventricular septal defect (PmVSD) occluder. The device is a specifically-designed implant indicated for the minimally...

Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint

Medtronic’s ENDURANCE Supplemental trial of the company’s HVAD ventricular assist device has failed to meet its primary endpoint of all neurological events at 12...

First patients enrolled in HLT’s Meridian transcatheter aortic valve feasibility study

HLT has announced that the first patient implants in a feasibility clinical study to assess the safety and performance outcomes of its Meridian transcatheter...

CE mark granted to NVT for Allegra transcatheter aortic valve

NVT has received the CE mark for its Allegra transcatheter aortic valve, which it describes as “distinctive” in a company release. The product features...

Reva receives CE mark for Fantom drug-eluting scaffold

Reva has been granted CE mark approval for its Fantom drug-eluting bioresorbable coronary scaffold. Fantom is Reva’s first commercial product. With this approval, Reva plans...

Insomnia associated with increased risk of heart attack and stroke

Insomnia is associated with increased risk of heart attack and stroke, according to new research published in the European Journal of Preventive Cardiology. “Sleep is...

Armetheon to merge with Espero Pharmaceuticals

Espero Pharmaceuticals and Armetheon are to merge to form a new company. Upon completion of the merger, which is expected to occur in the...

Boston Scientific agrees to acquire Symetis

Boston Scientific Corporation have definitively agreed to acquire Symetis, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation devices, for...

SynCardia to honour eight total artificial heart hospitals during ISHLT

  This year’s SynCardia awards recognise leadership in the Destination Therapy clinical trial, pioneering use of the 50cc Total Artificial Heart, outstanding outcomes, implant milestones...

Magnesium 1,000 programme reveals high deployment success for Biotronik’s Magmaris scaffold

Biotronik has released details of the clinical performance of its Magmaris magnesium scaffold in 1,000 cases as part of the Magnesium 1,000 programme. Among...

Cardiovascular Systems enrols first subject in ECLIPSE coronary clinical trial

Cardiovascular Systems and the Cardiovascular Research Foundation (CRF) have announced that the first subject has been enrolled in the ECLIPSE clinical trial. The subject...

iVascular Capturer 7F granted CE mark

iVascular has obtained CE mark for the thrombus extraction catheter Capturer 7F. The company claims that the device has outstanding extraction capacity, and the highest...

First US commercial case performed using Tryton Side branch stent

Tryton Medical has announced that the first US commercial case using the Tryton Side branch stent to treat a coronary bifurcation lesion involving a...

ACC 2017: Meta-analysis supports use of RenalGuard in cardiovascular Interventional procedures

A new meta-analysis presented this week at the American College of Cardiology 66th Scientific Sessions (ACC; 17-19 March, Washington DC, UK) offers support to...

Toshiba Medical’s AplioTM i900 cardiovascular ultrasound receives US FDA clearance

Cardiologists can now access the advanced ultrasound imaging technology needed for fast and confident diagnoses with Toshiba Medical’s Aplio i900. The newly US Food...

Siemens Healthineers and HeartFlow to integrate CT and FFRct Analysis technology

Siemens Healthineers and HeartFlow are to collaborate on joint-solution computed tomography (CT) scanners, intended to provide a comprehensive, noninvasive solution to support the diagnosis...

EBBINGHAUS trial shows non-inferiority of evolocumab for cognitive function in cardiovascular...

Amgen has announced detailed results from the evolocumab (Repatha) cognitive function trial (EBBINGHAUS) evaluating the impact on cognitive function in 1,974 patients enrolled in...

RaySafe unveils new real-time dosimeter

Unfors RaySafe has introduced the RaySafe i3, to its suite of real-time dosimetry products, at the European Society of Radiology in Vienna.   The RaySafe Real-Time...

ACC 2017: Positive final results from ORION-1 phase II study of...

The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORION-1 Phase II study of inclisiran, an investigational, first-in-class PCSK9 synthesis...

ACC 2017: TAVI Linked with bleeding in the brain and neurological...

Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarter developed new microbleeds in the brain after their procedure, according to...

BIOFLOW-IV confirms non-inferiority of Biotronik’s Orsiro in Japan

The 12-month results of Biotronik’s BIOFLOW-IV multicentre clinical study have been presented at the 2-17 Japan Circulation Society congress (JCS; 17-19 March, Kanazawa, Japan)....

ACC 2017: Embol-X and CardioGard do not reduce number of brain...

Two US Food and Drug Administration-cleared medical devices designed to remove potential vessel-blocking debris particles from the bloodstream during aortic valve replacement—EmbolX (Edwards LifeSciences)...

TAVI may benefit certain heart valve patients, update society guidelines say

New recommendations have been published by the American Heart Association and the American College of Cardiology, aiming to clarify which patients who have malfunctioning...

ACC 2017: Indigenous South American group has healthiest arteries ever studied

The Tsimane people—a forager-horticulturalist population of the Bolivian Amazon—have the lowest reported levels of vascular ageing for any population, with coronary atherosclerosis being five...

ACC 2017: Acarix trial finds 97% negative predictive value for CADScor...

Acarix has announced the results from a new multicentre trial of its handheld CADScor system for non-invasive, non-radiation acoustic detection of coronary artery disease....

ACC 2017: Mary Norine Walsh assumes American College of Cardiology presidency

Mary Norine Walsh has become president of the American College of Cardiology during the Convocation Ceremony held in conjunction with the society’s 66th Annual...

ACC 2017: Wrist-worn heart rate monitors less accurate than standard chest...

Researchers at Cleveland Clinic, Cleveland, USA, put five popular wrist-worn fitness trackers to the test to find out how accurately they gauge heart rate...

Coffee shops and cash machines ideal locations for lifesaving automated external...

Community coffee shops and cash machines might be ideal locations for public access to automated external defibrillators, according to new research published in Circulation. An...

ACC 2017: Researchers sound alarm over Zika’s potentially harmful effects on...

As the Zika virus continues to spread globally, new evidence has emerged about the virus’s potentially detrimental effects on the heart, according to data...

ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations...

Late-breaking clinical research presented at the American College of Cardiology 66th Annual Scientific Sessions (ACC; 17-19 March, Washington, DC, USA) has shown treatment with...

ACC 2017: More hospitalisations & deaths for US heart failure patients...

Patients with heart failure in the USA are more likely to be hospitalised and more likely to die during the colder winter months, according...

MR Solutions introduces 9.4T preclinical MRI imaging solution to cardiovascular sector

MR Solutions’ new 9.4 tesla cryogen-free preclinical scanners was demonstrated to cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic...

Clinical trial rules should protect patients and results not operational details,...

Rules governing the conduct of clinical trials are failing to produce the intended benefits for patients and should be rewritten through a transparent process...

UK Patents Court makes initial decision on Edwards Sapien 3 and...

The Patents Court in the UK has determined that one of Boston Scientific’s patents related to outer seals for transcatheter heart valves that was...

Illumina study completes enrolment

Alvimedica’s Illumina study has completed enrolment. The Illumina study has been designed to evaluate the efficacy and safety of the new self-expanding polymer free...

FDA grants approval to Tryton for side-branch stent

The US Food and Drug Administration (FDA) has approved Tryton Medical’s Premarket Approval (PMA) application for the Tryton side-branch stent for the treatment of...

Screening for heart disease may lead to prevention, better treatments

According to a review published in JACC: Cardiovascular Imaging, the simple computed tomography (CT) imaging technique of coronary artery calcium (CAC) scanning may be...

Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban

The first patient has been enrolled into Daiichi Sankyo’s ENTRUST-AF PCI study. The multinational, randomised phase 3b study will evaluate a treatment regimen based...

US FDA grants 510(k) clearance to Teleflex for TrapLiner catheter

Teleflex incorporated has announced 510(k) clearance by the US Food and Drug Administration (FDA), and the US commercial launch of the TrapLiner catheter. The TrapLiner...

Second successful annuloplasty performed using Micro Interventional Devices minimally invasive technology

The second clinical case using Micro Interventional Devices’ proprietary MIA (minimally invasive annuloplasty) technology for percutaneous mitral and tricuspid repair has been performed on...

LivaNova to delist from London Stock Exchange

LivaNova has applied for the voluntary cancellation of its standard listing of ordinary shares with the United Kingdom Listing Authority and to the London...

First patient treated with CardiAmp cell therapy for ischaemic heart failure...

Johns Hopkins Medicine, Baltimore, USA, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia have announced that the first patient has been treated in...

Few heart attack survivors get recommended physical activity

Only 16% of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalisation, according to a study by researchers...

Elsevier announces the launch of Case: Cardiovascular Imaging Case Reports

Elsevier and the American Society of Echocardiography has announced the launch of Case: Cardiovascular Imaging Case Reports. Case is an online, bi-monthly journal with the...

Physical activity may be more important than BMI for cardiovascular disease...

The benefits of physical activity may outweigh the impact of overweight and obesity on cardiovascular disease in middle-aged and elderly people, according to research...

Corindus Vascular Robotics announces private placement for US$45 million

Corindus Vascular Robotics has entered into a Securities Purchase Agreement pursuant to which it will issue and sell an aggregate of 67,941,346 shares of...

Martha Goldberg Aronson joins Cardiovascular Systems board of directors

Cardiovascular Systems (CSI) has announced the addition of independent board member Martha Goldberg Aronson, an experienced business executive with deep healthcare and medical industry...

Researchers urge physicians to discuss herbal medication use with heart disease...

Physicians should be well-versed in the herbal medications heart disease patients may take to be able to effectively discuss their clinical implications, potential benefits...

Following dietary recommendations leads to modest heart health improvements

Following current dietary recommendations may lead to small improvements in overall heart health in overweight individuals, according to a study published in the Journal...

Increased physical activity, lower BMI may lower heart failure risk

While lifestyle patterns, including physical activity and body mass index (BMI), are associated with overall heart failure risk, they are more strongly associated with...

European Society of Cardiology publishes special collection on eHealth revolution

How are smartphones and computer programs transforming healthcare, especially when it comes to preventing, diagnosing and treating heart disease? This is the focus of...

Teleflex completes acquisition of Vascular Solutions

Teleflex Incorporated has completed its previously announced acquisition of Vascular Solutions. On December 2, 2016, the two companies announced a definitive agreement for Teleflex...

Cardiovascular Systems Micro Crown sustains high freedom from major adverse events...

Cardiovascular Systems (CSI) has released one-year results from its Coronary Orbital Atherectomy System Study (COAST) in a late-breaking presentation at the 2017 Cardiovascular Research...

Intensive blood pressure control could prevent 100,000 deaths each year

Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the USA each year. “The public health impact of...

SentreHEART Lariat and Eclipse receive reimbursement renewal in Germany

The German Institute for the Hospital Remuneration System (InEK) has renewed Status 1—the highest of four levels—for SentreHEART’s Lariat and Eclipse left atrial appendage...

Symetis acquires Middle Peak Medical

Symetis, a medical technology company specialising in the development, manufacturing and marketing of percutaneous heart valve replacement solutions for the treatment of severe cardiac...

Medtronic launches Impact education and development programme in Europe, Middle East...

Medtronic has announced the launch of Medtronic Impact in the Europe, Middle East & Africa regions. Medtronic Impact is intended to introduce a new approach...

NICE recommends HeartFlow FFRct Analysis to aid the determination of stable...

The UK’s National Institute for Health and Care Excellence (NICE) has issued guidance today for use of the HeartFlow FFRct Analysis to help determine...

Plethysmography test predicts risk for cardiovascular disease

A new test that predicts an individual's risk for developing cardiovascular disease has been launched today by Everist Health. "The test is non-invasive and...

Chinese air pollution linked to respiratory and cardiovascular deaths

In the largest epidemiological study conducted in the developing world, researchers found that as exposures to fine particulate air pollution in 272 Chinese cities...

Medtronic releases DxTerity diagnostic catheters and transradial approach tool

  Medtronic has launched the DxTerity diagnostic angiography catheter line, and several transradial-specific products including the DxTerity TRA, InTRAkit access kit and TRAcelet compression device,...

First commercial procedures performed with Corindus CorPath GRX system

The first commercial procedures using Corindus Vascular Robotics’ CorPath GRX system have been performed following the company’s recent 510(k) clearance from the US Food...

US FDA agrees to 1000-patient pivotal trial of Armetheon’s tecarfarin

Armetheon has reached agreement with the US Food and Drug Administration (FDA) for a single 1000-patient final pivotal trial for its drug candidate, tecarfarin...

COMPASS study of rivaroxaban to end early for efficacy

The phase three COMPASS trial, evaluating the efficacy and safety of rivaroxaban (Xarelto, Bayer) for the prevention of major adverse cardiac events, including cardiovascular...

Cancer drug promotes regeneration of damaged heart tissue

An anticancer agent in development has been shown to promote regeneration of damaged heart muscle—an unexpected research finding that may help prevent congestive heart...

US FDA grants Fast Track designation to Angionetics’ Generx coronary heart...

The US Food and Drug Administration (FDA) has granted Angionetics “Fast Track” designation for the phase three clinical investigation of Generx cardiovascular angiogenic...

Study demonstrates sustained benefit of endovascular intervention in patients with lower...

Cardiovascular systems (CSI) presented six-month data from its LIBERTY 360 degrees post-market study in a presentation at the 29th International Symposium on Endovascular Therapy...

New guidelines released to improve stroke reporting following cardiac procedures

In response to a growing body of evidence of the existence of "covert" brain injury to patients undergoing transcatheter aortic valve implantation (TAVI) and...

Veryan Medical receives £13.5m further funding

Veryan Medical has received a further £13.5m of funding in the form of both equity and debt from its existing investors, including Touchstone Innovations,...

Evolocumab significantly reduces risk of cardiovascular events

The FOURIER trial evaluating whether evolocumab (Repatha, Amgen) reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD) has...

Edwards Lifesciences halts enrolment in Cardiaq trial

According to a SeekingAlpha transcript of an Edwards Lifesciences fourth-quarter 2016 earnings conference call, the company has put a halt on enrolment in its...

Patient enrolment begins in European Somahlution DuraGraft registry

Multiple sites in Spain have begun enrolling patients in the DuraGraft coronary artery bypass grafting (CABG) European Registry. The registry will evaluate Somahlution’s flagship...

Northwestern Memorial Hospital ranked best in USA for heart attack, stroke...

Northwestern Memorial Hospital has been ranked best in the USA for survival of patients suffering heart failure, and second for survival of patients with...

Latest statistics show heart failure on the rise

The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...

Frances Dea named new SCAI executive director

The Society for Cardiovascular Angiography and Interventions (SCAI) has named Francesca Dea, its new executive director. “Dea distinguished herself as a dynamic, forward-thinking executive with...

Edwards Lifesciences completes acquisition of Valtech Cardio

Edwards Lifesciences has closed its previously announced acquisition of Valtech Cardio, developer of the Cardioband system for transcatheter repair of the mitral and tricuspid...

Positive results for heart surgery in elderly aortic stenosis patients

Elderly patients with aortic stenosis and medium surgical risk experienced better than expected results after undergoing traditional surgical aortic valve replacement, according to research...

Next-generation troponin T test from Roche cleared by US FDA

Roche has received US Food and Drug Administration (FDA) 510(k) clearance for its Elecsys troponin T Gen 5 STAT (TnT Gen 5 STAT) blood...

Alvimedica receives CE mark for amphilimus-eluting Cre8 EVO stent

Alvimedica has received the CE mark for its new polymer-free amphilimus-eluting stent, Cre8 EVO. Cre8 EVO is designed to provide a controlled elution of the...

Medtronic receives CE mark for 34mm size CoreValve Evolut R

The CE mark has been granted to Medtronic for the 34mm-valve version of its CoreValve Evolut R, the largest sized transcatheter aortic valve implantation...

Robert Califf to resign as US FDA commissioner

Robert Califf is to step down as US Food and Drug Administration (FDA) commissioner upon the inauguration of Donald Trump as US President on...

Clínica Universidad de Navarra implants Spain’s first SynCardia Total Artificial Heart

A medical team from Clínica Universidad de Navarra in Pamplona, Spain, has successfully performed the country’s first implant of the SynCardia temporary Total Artificial...

Researchers discover mechanism linking stress to heart disease

Heightened activity in the amygdala has been associated with a greater risk of heart disease and stroke, according to a study published in The...

OrbusNeich releases next-generation coronary scoring balloon

OrbusNeich has launched the Scoreflex NC, a non-compliant scoring balloon targeting more resistant lesions. The product is a focused force dual-wire balloon system built...

New AHA/ACC guidance released for TAVI

A new expert consensus decision pathway will assist clinicians and hospitals in assessing patients’ eligibility for transcatheter aortic valve implantation (TAVI), performing the procedure...

Arterys receives US FDA clearance for cardio imaging analytics software

Arterys has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Arterys Cardio deep learning (DL) application. Arterys Cardio...

St Jude Medical announces Merlin cybersecurity updates

St Jude Medical has announced that it will immediately deploy the latest release of cyber security updates for its Merlin remote monitoring system, used...

The Medicines Company announces positive 180-day results for PCSK9 inhibitor

The Medicines Company has announced positive top-line results from the interim analysis with 180-day follow-up for all 501 patients enrolled in the ongoing ORION-1...

Medinol reports positive clinical results for Elunir elastomer-coated drug-eluting stent

Twelve-month clinical results from Medinol’s BIONICS study have demonstrated that the company’s Elunir stent has a good safety profile, among other positive results. The study...

ACC releases new appropriate use criteria for coronary revascularisation

The American College of Cardiology (ACC), along with several partnering organisations, has released updated appropriate use criteria for performing coronary revascularisation in patients with...

Women fare better than men one year after transcatheter aortic valve...

Women with significant aortic valve disease who undergo transcatheter aortic valve implantation (TAVI) have been traditionally considered at a higher risk than men in...

New ACC/AHA report outlines 10 measures for the prevention of sudden...

A new report from the American College of Cardiology and the American Heart Association presents 10 quality and performance measures that are intended to...

Micro Interventional Devices has first-in-human success with MIA technology

Micro Interventional Devices has successfully completed the first clinical implantation of its proprietary MIA (minimally invasive annuloplasty) technology for minimally invasive mitral and tricuspid...

Blood troponin level could predict silent heart disease risk

A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new research funded by...

US FDA bans powdered gloves

The US Food and Drug Administration (FDA) has issued a final rule to ban powdered surgical gloves, patient examination gloves and the absorbable powder...

NICE collaborates with US FDA on Payer Communication Taskforce

The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication...

Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...

Patients with acute coronary syndrome at increased risk of suicide

Patients with acute coronary syndrome may be at an increased risk for suicide compared to otherwise healthy people, according to new research in the Journal...

Boston Scientific closes acquisition of certain Neovasc assets

Boston Scientific Corporation has closed its acquisition of certain manufacturing assets and capabilities of the Neovasc advanced biological tissue business. With the completion of...

AngioSoma appoints new chief executive officer

AngioSoma has appointed Ken Stephenson as chief executive officer, board member, and president of the company. Having set up and worked with interventional radiologists and...

4Tech appoints Michael Ennen as president and chief executive officer

4Tech has appointed Michael Ennen as president and chief executive officer, effective immediately. Ennen succeeds co-founder Carine Schorochoff, who will continue to serve 4Tech...

Japan’s Ministry of Health, Labor and Welfare approves reimbursement for Medtronic’s...

Medtronic has been granted reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its recapturable, self-expanding transcatheter CoreValve Evolut R...

Boston Scientific to acquire Neovasc biological tissue capabilities

Boston Scientific has agreed to acquire certain manufacturing assets and capabilities of the Neovasc advanced biological tissue business, as well as a 15% equity...

Medtronic first to receive CE mark for less-invasive HVAD implant procedure

Medtronic’s HVAD system left ventricular assist device (LVAD) has received the CE mark for a less-invasive implant procedure in patients with advanced heart failure....

Toshiba receives US FDA clearances for new CT reconstruction tech and...

Toshiba Medical’s Forward projected model-based iterative reconstruction solution (FIRST) and Vantage Titan 1.5T/cS edition with M-Power v3.6 software have received US Food and Drug...

Amsel Medical to present Occluder research at ICI 2016

Amsel Medical Corporation is to present initial animal results of its “A Novel Mechanical Closure Device for Left Atrial Appendage Orifice and Closure of...

Complete sanitation of robotic surgical instruments virtually impossible

It is virtually impossible to remove all contamination from robotic surgical instruments, even after multiple cleanings, according to a study published in Infection Control...

London Valves 2016: Edwards announces SAPIEN 3™ valve CE Mark approved...

PCR London Valves 2016 opened in the main arena with the Edwards Lifesciences TNT session "TAVI in 2016: the year the treatment of aortic...

US FDA issues Class I recall for 8040 Leonhard Lang multifunction...

The Leonhard Lang defibrillation electrode DF29N is being recalled due to a connector compatibility issue with the Welch Allyn AED model 10. The FDA...

St. Jude Medical and Abbott to sell portion of vascular closure...

Abbott and St. Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase price of...

Philips collaborates with World Heart Federation, launches health behaviours website

Royal Philips has announced a new partnership with the World Heart Federation (WHF) to help people better manage their heart health.  Aligned with the...

Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication

Opsens has announced 510(k) clearance from the US Food and Drug Administration (FDA) for the OptoMonitor II, a new multimodality monitor designed to combine the...

Young women with premature acute coronary syndrome now do as well...

It has become commonly accepted that women do worse than men following a heart attack or other coronary event. Earlier studies have documented that...

Visceral abdominal fat associated with newly-identified heart disease risk factors

Increasing stomach fat—especially abdominal visceral fat—has been associated with newly- Framingham Heart Study identified and worsening heart disease risk factors, according to a study...

Sapien 3 now approved for intermediate-risk patients in Europe as well...

Following last month’s FDA approval for the expanded indication of Sapien 3 for the treatment of intermediate-risk patients with aortic stenosis, the device can...

Researchers find new carotid body-removal treatment for hypertension

A team of clinical scientists at the University of Bristol (Bristol, UK) have found a new way to treat hypertension. The research study, entitled...

ESC launches European standards to prevent repeat heart attacks

European standards to prevent repeat heart attacks have been published in the European Journal of Preventive Cardiology. The standards were defined by the European...

Berlin Heals announces closure of second round funding for cardiac microcurrent...

Berlin Heals has closed a second investment round in the run-up to the first-in-man application of its implantable medical device for the treatment of...

Vivasure Medical secures €16.2 million series C financing

Vivasure Medical has announced that the company has completed a series C financing of €16.2 million. The round was led by LSP (Life Sciences Partners)...

Risk factors for congenital heart defects may lie both inside and...

In new research published in PLOS Biology, University of California, Irvine (Irvine, USA) biologists Anne Calof and Arthur Lander and colleagues report that the...

Medtronic ranks on Dow Jones Sustainability North America Index for ninth...

Medtronic has been recognised as one of the world's leading companies for sustainability, ranking on the Dow Jones Sustainability North America Index (DJSI North...

St Jude Medical launches trial of Amplatzer Amulet left atrial appendage...

The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will evaluate the safety and effectiveness of the company’s Amplatzer Amulet left...

Women 50% more likely than men to be given incorrect diagnosis...

Women have a 50% higher chance than men of receiving the wrong initial diagnosis following a heart attack, according to a new study. The...

Synthetic heart valves could help doctors improve surgical skills

A University of British Columbia (Vancouver, Canada) invention has made it possible for doctors to vastly improve their bypass surgery techniques without relying on...

ESC 2016: Low socioeconomic status associated with higher risk of second...

Low socioeconomic status has been associated with a higher risk of a second heart attack or stroke, according to research presented at the ESC...

ESC launches paper on tackling cardiac toxicity of anticancer therapies

The European Society of Cardiology has launched a novel position paper, under the auspices of its Committee for Practice Guidelines, on tackling the cardiac...

Philips launches Intellispace Cardiovascular image and information management system

Royal Philips has launched the IntelliSpace Cardiovascular 2.1, the latest version of its next-generation Cardiovascular Image and Information Management System. IntelliSpace Cardiovascular is designed...

Mediterranean diet linked to lower mortality in patients with a history...

The Mediterranean diet has been associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from...

ESC and EACTS launch first collaborative atrial fibrillation guidelines

The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) have been...

Fewer cardiovascular drugs being studied in clinical trials

The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years— even as cardiovascular...

Edwards Sapien 3 granted expanded indication from US FDA

Edwards Lifesciences has announced US Food and Drug Administration (FDA) approval to expand use of the Edwards Sapien 3 transcatheter heart valve for the...

Renal denervation devices are alternatives to drug therapy, Technavio reports

Analysts from Technavio have forecast the global renal denervation market to grow at a compound annular growth rate of close to 12% during the...

CE mark granted to InSeal Medical for InClosure vascular closure device

InSeal Medical has received CE mark approval for its InClosure VCD; a large bore vascular closure device. According to a press release, the InClosure...

US FDA commissioner discusses future of cardiovascular medicine

Advances in technology coupled with an increased use of social media and personal devices could offer new possibilities for treating patients and improving outcomes,...

Corindus appoints J Aaron Grantham as chief medical officer

Corindus Vascular Robotics has announced that J Aaron Grantham, an interventional cardiologist specialising in the treatment of chronic total occlusions, has joined the company...

Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for...

Medtronic has received CE marking for the self-expanding, recapturable and repositionable CoreValve Evolut R system to treat aortic stenosis patients who are at intermediate...

Mediterranean diet without low-fat element reduces cardiovascular events

Hanna E Bloomfield (Minneapolis VA Medical Center, Minneapolis, USA) and others report in Annals of Internal Medicine that limited evidence, from randomised control trials, indicates...

What is required for TAVI to become the new gold standard?

Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of aortic stenosis and has entered international guideline recommendations.1,2...

First patients treated with CorMatrix Cardiovascular Tyke

The first patients have been treated using CorMatrix Cardiovascular’s Tyke. The product received US Food and Drug Administration 510(k) clearance in February 2016. It is...

First patient enrolled in AtriCure FROST cryoanalgesia study

The first patient has been enrolled in the FROST study at William Beaumont Hospital, Dearborn, USA. This AtriCure-sponsored trial will evaluate intraoperative cryoanalgesia therapy...

Small study finds positive results for Neovasc’s Reducer system treatment for...

Positive results of a single-centre, retrospective study using the Neovasc Reducer have been published in The Netherlands Heart Journal. The paper documents the results...

Immune system linked to lower heart attack risk, suggests study

Measuring antibody levels in the blood could be used to detect a person’s heart attack risk after researchers, part-funded by the British Heart Foundation,...

St Jude Medical HeartMate 3 wins CARDIOSTIM-EHRA EUROPACE 2016 Innovation Award

St Jude Medical has received an Innovation Award for its HeartMate 3 left ventricular assist system (LVAS) at the 2016 CARDIOSTIM EHRA EUROPACE International...

Biotronik’s scaffold is now approved for use in Europe

Biotronik’s bioresorbable magnesium scaffold—Magmaris—is now CE mark approved, meaning it is now one of three bioresorbable scaffolds available on the European market (alongside Abbott...

Cardiovascular News Issue 41 – May 2016

Highlights - TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred stenting in STEMI patients does not improve outcomes; Usman...

Cardiovascular News Issue 41 – May 2016 US Edition

Highlights - TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred stenting in STEMI patients does not improve outcomes; Usman...

Cardiovascular News Issue 40 – February 2016 US Edition

Highlights - ABSORB III supports previous findings that Absorb is noninferior to Xience at one year; IVUS-guided stent implantation significantly reduces risk of major...

Cardiovascular News Issue 40 – February 2016

Highlights - ABSORB III supports previous findings that Absorb is noninferior to Xience at one year; IVUS-guided stent implantation significantly reduces risk of major...

Cardiovascular News Issue 39 – October 2015

Highlights - Novel diagnostic strategy may "dramatically reduce need for invasive tests"; New tools needed for optimising dual antiplatelet therapy duration; Marco Roffi on...

Cardiovascular News Issue 39 – October 2015 US edition

Highlights - Novel diagnostic strategy may "dramatically reduce need for invasive tests"; New tools needed for optimising dual antiplatelet therapy duration; Marco Roffi on...

Cardiovascular News Issue 38 – August 2015

Highlights: -Sapien XT and CoreValve have comparable mortality at one year -Current recommendations on multivessel PCI may need to be reconsidered -Maciej Lesiak: PCI...

Cardiovascular News Issue 38 – August 2015 US Edition

Highlights: -Sapien XT and CoreValve have comparable mortality at one year -Current recommendations on multivessel PCI may need to be reconsidered -Maciej Lesiak: PCI...

Cardiovascular News Issue 37 – May 2015 US Edition

Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest CoreValve should be preferred option for high-risk patients" -Wayne Batchelor:...

Cardiovascular News Issue 37 – May 2015

Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest CoreValve should be preferred option for high-risk patients" -Wayne Batchelor:...

Cardiovascular News Issue 36 – February 2015

Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical...

Cardiovascular News Issue 36 – February 2015 US Edition

Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical...

Cardiovascular News Issue 35 – September 2014

Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients...

Cardiovascular News Issue 35 – September 2014 US Edition

Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients...

Cardiovascular News Issue 34 – August 2014

Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert...

Cardiovascular News Issue 34 – August 2014 US Edition

Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert...

Cardiovascular News Issue 33 – May 2014

Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than...

Cardiovascular News Issue 33 – May 2014 US Edition

Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than...

Cardiovascular News Issue 32 – February 2014

Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by...

Cardiovascular News Issue 32 – February 2014 US Edition

Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by...

Cardiovascular News Issue 31 – October 2013

Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be...

Cardiovascular News Issue 31 – October 2013 US Edition

Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be...

Cardiovascular News issue 30 – August 2013

Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in...

Cardiovascular News issue 30 – August 2013 US edition

Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in...

Cardiovascular News issue 29 – May 2013

Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce...

Cardiovascular News issue 29 – May 2013 US edition

Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce...

Cardiovascular News Issue 27 – October 2012 US edition

Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with...

Cardiovascular News Issue 27 – October 2012

Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with...

Cardiovascular News Issue 26 – August 2012 US edition

Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy...

Cardiovascular News Issue 26 – August 2012

Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy...

Cardiovascular News Issue 25 – May 2012

Highlights: -TAVI as effective as surgery in high-risk patients at two years -Sustained blood pressure reduction achieved with renal denervation out to three years...

Cardiovascular News Issue 24 – February 2012 EU edition

Highlights: -iFR vasodilator-free measure of stenosis severity comparable to FFR -PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery -MRI safe in patients with selected...

Cardiovascular News Issue 24 – February 2012 US edition

Highlights: -iFR vasodilator-free measure of stenosis severity comparable to FFR -PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery -MRI safe in patients with selected...

Cardiovascular News Issue 23 – November 2011

Highlights: -Lower thrombosis risk with newer generation drug-eluting stents -Intra-aortic balloon counterpulsation does not appear to provide benefit -"Prasugrel or ticagrelor should be administered to patients at...

Cardiovascular News Issue 22 – August 2011

Highlights: -FFR-CT technique can cut unnecessary coronary procedures -"TAVI should be performed with cerebral protection" -Pioneer of interventional cardiology in China receives Ethica Award 2011 -Profile: Martyn Thomas http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-22.pdf  

Cardiovascular News Issue 21 – May 2011

Highlights: -PARTNER find TAVI as good as surgery -Absorb shows positive one-year safety and efficacy results -Profile: Ralph Brindis http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-21.pdf  

Cardiovascular News Issue 20 – Feb 2011

Highlights - New absorbable stent era begins - TAVI improves quality of life in inoperable patients - Profile: Roberto Ferrari http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-20.pdf  

Cardiovascular News Issue 19 – Sept 2010

Highlights - ESC sees SHIFT in heart failure treatment - FDA advisory committe recommends approval of tricagrelor for acute coronary syndromes - Interview - George Dangas - New...

Cardiovascular News Issue 18 – Jul 2010

Highlights - "Encouraging" TAVI results in high-risk patients - Bioresorbable stent one step closer to becoming reality - Profile: Josep Brugada http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/18-Cardiovascular-Int_low-res.pdf  

Cardiovascular News Issue 17 – Apr 2010

Highlights - NO ACCORDance on role of fibrates - Cypher versus ENDEAVOR trial results cause stir - Profile: Christopher Paul Cannon http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/17-Cardiovascular-News_for-Web.pdf  

Cardiovascular News Issue 16 – Jan 2010

Highlights - Controversy surrounds long-term lipid lowering therapy - SPIRIT IV and COMPARE trials show positive results - Profile: Alfredo Galassi http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/16-Cardiovascular-News_for-Web.pdf  

Cardiovascular News Issue 15 – Sep 2009

Highlights - New drugs steal the spotlight at the ESC Congress - SYNTAX at two years: Comparable outcomes for stenting and bypass surgery in complex patients -...

Cardiovascular News Issue 14 – Aug 2009

Highlights - Drug-eluting stents "warranted" for infarction - Syntax Score website: A tool for the best strategy - Profile: Silvia Priori http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-14.pdf  

Cardiovascular News Issue 13 – May 2009

Highlights - Percutaneous mitral valve repair takes off - Antiplatelet agent prasugrel receives CE mark - Profile: Christian Hamm http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-13.pdf  

Cardiovascular News Issue 12 – Jan 2009

Highlights - JUPITER: reduced events in patients with low LDL cholesterol, raised CRP - FFR-guided stenting improves outcomes with fewer devices in the FAME trial http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-12.pdf

A quarter of an hour of exercise per day may reduce...

A study, which was presented at EuroPRevent 2016 (14–15 June, Sophia Antipolis, France), indicates that 15 minutes of daily exercise may be reasonable target for older...

Current issues in PCI: The latest data

The first edition of Current issues in PCI, which was published as a supplement alongside the February issue of Cardiovascular News, reported on the...

Current issues in PCI

The Stenting in Complex PCI meeting (2 December 2014, Milan, Italy) reviewed some of the most important issues in percutaneous coronary intervention (PCI) today. This...

DAPT and DES in coronary artery disease: Is it time to...

At a roundtable organised by Cardiovascular News, with an unrestricted educational grant from Medtronic, interventional cardiologists Sigmund Silber, Azeem Latib and Alexandre Abizaid discussed...

“Orsiro is a great example of some of the latest developments...

Cardiovascular News interviews Francesco Bedogni from Sant’Ambrogio Hospital, Milan, Italy, on the development of drug-eluting stent therapy, crucial factors choosing the right stent for...